TapewireFind a company

person · Reporting owner

Abbey Donald

Disclosed activity across 2 companies

Tapewire entity
47800
SEC CIK
0001534342

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DEXCOM INCDXCM · Entity 3114EVP Global Business Services IMarch 10, 2023March 14, 2023
ICU MEDICAL INC/DEICUI · Entity 2385DirectorMay 13, 2026May 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DEXCOM INC

Report date March 10, 2023 · Filed March 14, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect208,023 Last balance in matching sequence After 2023-03-10 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2023-03-10 · Disposition to issuer · Disposed 3,604 · Balance 216,088

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Row 2 · 2023-03-10 · Disposition to issuer · Disposed 4,675 · Balance 211,413

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Row 3 · 2023-03-10 · Disposition to issuer · Disposed 3,390 · Balance 208,023

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

ICU MEDICAL INC/DE

Report date May 13, 2026 · Filed May 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,004 Reported balance After 2026-05-13 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 6,004

F1: These securities are Restricted Stock Units.

Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13Direct0 Reported balance After 2026-05-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13Direct1,475 Reported balance After 2026-05-13 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Filing footnotes · ownership attribution and instrument terms

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 13, 2026 Filed May 14, 2026 00:52 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 1,475 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001534342-26-000008 · primary_doc.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2026 Filed May 14, 2026 00:52 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock · Derivative 1,254 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001534342-26-000008 · primary_doc.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2027-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2026 Filed May 14, 2026 00:52 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 1,254 $0.00 $0.00
Disclosure

SEC source: 0001534342-26-000008 · primary_doc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 25, 2026 Filed Mar 26, 2026 18:15 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 OtherCommon Stock 704 $0.00 $0.00
Disclosure

SEC source: 0001534342-26-000007 · primary_doc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,046

F1 · kind: Represents transfer of shares of common stock by the reporting person pursuant to a domestic relations order. The reporting person no longer has a reportable beneficial interest in the shares transferred.

F1 · shares: Represents transfer of shares of common stock by the reporting person pursuant to a domestic relations order. The reporting person no longer has a reportable beneficial interest in the shares transferred.

Read SEC document
May 13, 2025 Filed May 14, 2025 00:02 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock · Derivative 1,723 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-25-070752 · ownership.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,723 shares

Expires 2025-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2025 Filed May 14, 2025 00:02 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 1,254 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-25-070752 · ownership.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,254

Underlying: Common Stock · 1,254 shares

Expires 2026-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2025 Filed May 14, 2025 00:02 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 1,723 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-070752 · ownership.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 15, 2024 Filed May 15, 2024 22:10 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock · Derivative 948 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-060654 · ownership.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 948 shares

Expires 2024-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 15, 2024 Filed May 15, 2024 22:10 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 1,723 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-060654 · ownership.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,723 shares

Expires 2025-05-15

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 15, 2024 Filed May 15, 2024 22:10 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 948 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-060654 · ownership.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 17, 2023 Filed May 18, 2023 16:37 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 948 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-030517 · doc4.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 948

Underlying: Common Stock · 948 shares

Expires 2024-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2023 Filed May 18, 2023 16:37 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-030517 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 485 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2023 Filed May 18, 2023 16:37 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 485 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-030517 · doc4.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:45 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 3,390 $111.40 $377,642.61
Disclosure

SEC source: 0001093557-23-000074 · edgardoc.xml · nonDerivative · entry 3

Abbey Donald · CIK 0001534342 · EVP Global Business Services I

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,023

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:45 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 4,675 $111.40 $520,790.33
Disclosure

SEC source: 0001093557-23-000074 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP Global Business Services I

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,413

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:45 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 3,604 $111.40 $401,482.00
Disclosure

SEC source: 0001093557-23-000074 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Global Business Services I

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,088

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 21:02 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 18,776 $0.00 $18.78
Disclosure

SEC source: 0001093557-23-000061 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Global Business Services I

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,692

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 39,132 unvested restricted stock units. 18,776 granted on March 8, 2023 shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:14 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantNon-Qualified Stock Option (right to buy) · Derivative 1,270 $0.00 Strike: $185.79 $0.00
Disclosure

SEC source: 0001209191-22-029948 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270

Underlying: Common Stock · 1,270 shares

Expires 2033-05-17

F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 17, 2022 Filed May 18, 2022 16:14 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 485 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029948 · doc4.xml · derivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires 2023-05-17

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:00 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock · Derivative 433 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028497 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 433 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2022 Filed May 12, 2022 19:00 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 433 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-028497 · doc4.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:21 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 1,180 $406.06 $479,146.91
Disclosure

SEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 4

Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,229

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:21 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 932 $406.06 $378,444.84
Disclosure

SEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 3

Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,409

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:21 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 1,317 $406.06 $534,776.67
Disclosure

SEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,341

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 08, 2022 Filed Mar 11, 2022 00:21 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 4,984 $0.00 $4.98
Disclosure

SEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,658

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 23:59 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 15 $542.01 $8,130.16
Disclosure

SEC source: 0001093557-21-000212 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,674

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 13,673 restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 23:59 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,248 $541.36 $675,617.28
Disclosure

SEC source: 0001093557-21-000212 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,689

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 13,673 restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:08 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantNon-Qualified Stock Options (right to buy) · Derivative 1,295 $0.00 Strike: $196.57 $0.00
Disclosure

SEC source: 0001209191-21-031993 · doc4.xml · derivative · entry 4

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,295

Underlying: Common Stock · 1,295 shares

Expires 2032-05-11

F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:08 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 433 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-031993 · doc4.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 433

Underlying: Common Stock · 433 shares

Expires 2022-05-11

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:08 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock · Derivative 468 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-031993 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 468 shares

Expires 2021-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:08 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 468 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-031993 · doc4.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 22:36 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 5,566 $362.92 $2,019,996.02
Disclosure

SEC source: 0001093557-21-000071 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,937

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 16,171 restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
March 08, 2021 Filed Mar 11, 2021 00:24 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 5,301 $0.00 $5.30
Disclosure

SEC source: 0001093557-21-000049 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,503

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 16,171 restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2020 Filed Sep 11, 2020 22:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 3,297 $398.30 $1,313,201.69
Disclosure

SEC source: 0001093557-20-000247 · edgardoc.xml · nonDerivative · entry 3

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,202

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 22,722 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
September 09, 2020 Filed Sep 11, 2020 22:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,283 $398.30 $511,021.47
Disclosure

SEC source: 0001093557-20-000247 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,499

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 22,722 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
September 09, 2020 Filed Sep 11, 2020 22:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 5,159 $391.00 $2,017,169.00
Disclosure

SEC source: 0001093557-20-000247 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,782

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F2 · balance_after: Included in this number are 22,722 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,320 $428.58 $565,720.98
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 7

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,941

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F9 · price: This transaction was executed in multiple trades at prices ranging from $428.52 to $428.88. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,227 $427.61 $524,678.08
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 6

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,261

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F8 · price: This transaction was executed in multiple trades at prices ranging from $427.41 to $428.19. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,000 $426.66 $426,661.80
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 5

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,488

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F7 · price: This transaction was executed in multiple trades at prices ranging from $426.254 to $426.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 400 $425.15 $170,061.00
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 4

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,488

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F6 · price: This transaction was executed in multiple trades at prices ranging from $424.74 to $425.565. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,500 $423.69 $635,532.00
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 3

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,888

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F5 · price: This transaction was executed in multiple trades at prices ranging from $423.49 to $424.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 2,493 $423.18 $1,054,986.24
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,388

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F4 · price: This transaction was executed in multiple trades at prices ranging from $422.409 to $423.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
August 24, 2020 Filed Aug 26, 2020 23:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,826 $421.46 $769,586.87
Disclosure

SEC source: 0001093557-20-000232 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,881

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.

F2 · price: This transaction was executed in multiple trades at prices ranging from $421.119 to $421.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
May 13, 2020 Filed May 14, 2020 16:54 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantNon-Qualified Stock Option (right to buy) · Derivative 1,438 $0.00 Strike: $181.99 $0.00
Disclosure

SEC source: 0001209191-20-029075 · doc4.xml · derivative · entry 4

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,438

Underlying: Common Stock · 1,438 shares

Expires 2030-05-13

Read SEC document
May 13, 2020 Filed May 14, 2020 16:54 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 GrantCommon Stock · Derivative 468 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-029075 · doc4.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468

Underlying: Common Stock · 468 shares

Expires 2021-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2020 Filed May 14, 2020 16:54 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Sock · Derivative 378 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-029075 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 378 shares

Expires 2020-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.

Read SEC document
May 13, 2020 Filed May 14, 2020 16:54 UTC ICU MEDICAL INC/DE ICUI · Entity 2385 Exercise / conversionCommon Stock 378 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-029075 · doc4.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 693

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2020 Filed Mar 14, 2020 01:28 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 7,729 $265.43 $2,051,477.55
Disclosure

SEC source: 0001093557-20-000104 · edgardoc.xml · nonDerivative · entry 4

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,707

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 11, 2020 Filed Mar 14, 2020 01:28 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 105 $249.17 $26,162.33
Disclosure

SEC source: 0001093557-20-000104 · edgardoc.xml · nonDerivative · entry 3

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,436

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 11, 2020 Filed Mar 14, 2020 01:28 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 2 $246.35 $492.70
Disclosure

SEC source: 0001093557-20-000104 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,541

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.